• 9111747174
  • blinkcuremeds@gmail.com

Macugen 0.3mg Infusion

₹ 44,571.42₹ 44,571.42

Quantity :

Category :Medicines

Sub Category :hypertension care

Stock: Available

Macugen 0.3mg Infusion is used in the treatment of eye condition called wet age-related macular degeneration. It reduces the abnormal growth of blood vessels in the eye. This decreases the chances of swelling as well as fluid and blood leakage that can cause vision loss. Macugen 0.3mg Infusion is administered directly into the eyeball by an eye specialist. You should not self administer this medicine at home. The common side effects include eye pain, redness, blurred or decreased vision and eye discharge.However, if you experience these side effects for a longer duration or any other symptoms which you think may be due to this medicine, please inform your doctor. It is not advised to drive after administration of this injection as you may feel sleepy or dizzy and your alertness may be reduced.

Composition

Pegaptanib (0.3mg)

Primary Uses

Wet age-related macular degeneration

Common Side Effects

Punctate keratitis | High blood pressure | Conjunctival hemorrhage | Cataract | Increased intraocular pressure | Eye pain | Corneal edema | Blurred vision | Eye discomfort | Eyelid inflammation | Diarrhea | Nausea | Anterior chamber inflammation | Eye discharge | Eye irritation | Reduced visual acuity | Visual disturbance | Vitreous floaters | Vitreous opacities | Vitreous haemorrhage | Conjunctivitis | Photopsia (presence of perceived flashes of light) | Bronchitis (inflammation of the airways) | Dizziness | Headache | Urinary tract infection | Corneal epithelial disorders | Joint inflammation | Diabetes | Chest pain | Contact dermatitis | Carotid artery disease

Alcohol Interaction

CONSULT YOUR DOCTOR

Pregnancy

SAFE IF PRESCRIBED

Breast Feeding

SAFE IF PRESCRIBED

Driving

UNSAFE

Kidney Disease

CONSULT YOUR DOCTOR

Liver Disease

CONSULT YOUR DOCTOR

Add A Review

Your email address will not be published. Required fields are marked

Your Rating *

You need to Login OR Register

0 (Overall)

Based on 0 Comments